Which has grown faster, CNC or WST?

Over the past five years, CNC grew revenue faster — CNC at a 10.35% CAGR versus WST at 5.68%.

Does CNC or WST pay a bigger dividend?

WST pays a dividend (0.26% yield), while CNC has no payments in the available dividend history.

Is CNC or WST more profitable?

WST runs the higher net margin — CNC at -2.63% versus WST at 16.98%.

How have CNC and WST total returns compared?

Over the past 10 years, CNC delivered 7.11% and WST delivered 15.86% annualized total return. Past performance doesn't predict future results.

Centene Corp. (CNC) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of Centene Corp. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

CNC

Centene Corp.

$30.53B

$61.80HealthcareDelayed quote: Sep 25, 2026, 3:59 PM EDT

WST

West Pharmaceutical Services, Inc.

$26.06B

$370.29HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — CNC vs WST

growth of $100 · dividends reinvested · last 10y

CNC +92.5% (+6.8%/yr)WST +318.5% (+15.4%/yr)WST compounded faster over this window

CNC WST

CNC vs WST: by the numbers

•CNC is the larger company ($30.53B vs $26.06B market cap).
•WST is profitable (16.98% net margin) while CNC runs a net loss (-2.63%).
•CNC grew revenue faster over the past five years (10.35% vs 5.68% CAGR).
•WST pays a dividend (0.26% yield), while CNC has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CNC	WST
P/E ratio	N/A	47.35
Forward P/E	12.87	41.30
P/S ratio	0.16	7.83
P/B ratio	1.35	8.71
EV / EBITDA	N/A	29.92
FCF yield	29.38%	1.68%

Profitability

Metric	CNC	WST
Gross margin	16.13%	36.77%
Operating margin	-2.82%	20.64%
Net margin	-2.63%	16.98%
ROE	-22.60%	18.89%
ROIC	-12.90%	15.77%

Dividends

Metric	CNC	WST
Dividend yield	N/A	0.26%
Payout ratio	N/A	11.25%

Growth (annualized)

Metric	CNC	WST
Revenue CAGR (5Y)	10.35%	5.68%
EPS CAGR (5Y)	N/A	7.85%
FCF CAGR (5Y)	-1.39%	8.74%
Total return CAGR (5Y)	2.15%	-5.84%

Frequently asked

Which has grown faster, CNC or WST?: Over the past five years, CNC grew revenue faster — CNC at a 10.35% CAGR versus WST at 5.68%.
Does CNC or WST pay a bigger dividend?: WST pays a dividend (0.26% yield), while CNC has no payments in the available dividend history.
Is CNC or WST more profitable?: WST runs the higher net margin — CNC at -2.63% versus WST at 16.98%.
How have CNC and WST total returns compared?: Over the past 10 years, CNC delivered 7.11% and WST delivered 15.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CNC analysis Full WST analysis Interactive comparison tool

Dig into the metrics

West Pharmaceutical Services P/E ratio West Pharmaceutical Services dividend yield Centene ROE West Pharmaceutical Services ROE Centene operating margin West Pharmaceutical Services operating margin Centene revenue growth West Pharmaceutical Services revenue growth Centene free cash flow West Pharmaceutical Services free cash flow

Centene & West Pharmaceutical Services appear in these rankings

25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.